Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1989 1
1991 2
1992 3
1993 2
1994 2
1995 5
1996 6
1997 6
1998 3
1999 2
2000 2
2001 11
2002 8
2003 8
2004 10
2005 8
2006 7
2007 6
2008 17
2009 17
2010 21
2011 20
2012 23
2013 21
2014 21
2015 18
2016 14
2017 11
2018 18
2019 17
2020 16
2021 16
2022 14
2023 9
2024 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

339 results

Results by year

Filters applied: . Clear all
Page 1
Non-suppressible viraemia during HIV-1 therapy: a challenge for clinicians.
Esteban-Cantos A, Montejano R, Pinto-Martínez A, Rodríguez-Centeno J, Pulido F, Arribas JR. Esteban-Cantos A, et al. Among authors: pulido f. Lancet HIV. 2024 May;11(5):e333-e340. doi: 10.1016/S2352-3018(24)00063-8. Epub 2024 Apr 8. Lancet HIV. 2024. PMID: 38604202 Review.
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice.
Suárez-García I, Alejos B, Hernando V, Viñuela L, Vera García M, Rial-Crestelo D, Pérez Elías MJ, Albendín Iglesias H, Peraire J, Tiraboschi J, Díaz A, Moreno S, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Suárez-García I, et al. J Antimicrob Chemother. 2023 Jun 1;78(6):1423-1432. doi: 10.1093/jac/dkad102. J Antimicrob Chemother. 2023. PMID: 37099559 Free PMC article.
Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients With HIV.
Berenguer J, Jarrín I, Bellón JM, Díez C, Jiménez-Sousa MA, López JC, Pinto-Martínez A, Moreno S, Montes ML, Iribarren JA, Orviz E, Portilla J, Villarroya F, Domingo P, Resino S; CoRIS Cohort. Berenguer J, et al. J Infect Dis. 2024 Aug 16;230(2):421-425. doi: 10.1093/infdis/jiae168. J Infect Dis. 2024. PMID: 38557859
Genetic barrier to resistance for dolutegravir.
Llibre JM, Pulido F, García F, García Deltoro M, Blanco JL, Delgado R. Llibre JM, et al. Among authors: pulido f. AIDS Rev. 2015 Jan-Mar;17(1):56-64. AIDS Rev. 2015. PMID: 25472016 Review.
Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people ≥65 years of age.
Maggiolo F, Rizzardini G, Molina JM, Pulido F, De Wit S, Vandekerckhove L, Berenguer J, D'Antoni ML, Blair C, Chuck SK, Piontkowsky D, Martin H, Haubrich R, McNicholl IR, Gallant J. Maggiolo F, et al. Among authors: pulido f. HIV Med. 2023 Jan;24(1):27-36. doi: 10.1111/hiv.13319. Epub 2022 May 8. HIV Med. 2023. PMID: 35527425 Free PMC article. Clinical Trial.
Treatment of advanced HIV infection.
Pulido F, Arribas JR. Pulido F, et al. J Antimicrob Chemother. 2003 Feb;51(2):225-7. doi: 10.1093/jac/dkg065. J Antimicrob Chemother. 2003. PMID: 12562685 Review. No abstract available.
Past and future of HIV infection. A document based on expert opinion.
Bouza E, Arribas JR, Alejos B, Bernardino JI, Coiras M, Coll P, Del Romero J, Fuster MJ, Górgolas M, Gutiérrez A, Gracia D, Hernando V, Martínez-Picado J, Martínez Sesmero JM, Martínez E, Moreno S, Mothe B, Navarro ML, Podzamczer D, Pulido F, Ramos JT, Ruiz-Mateos E, Suárez García I, Palomo E. Bouza E, et al. Among authors: pulido f. Rev Esp Quimioter. 2022 Apr;35(2):131-156. doi: 10.37201/req/083.2021. Epub 2022 Jan 12. Rev Esp Quimioter. 2022. PMID: 35018404 Free PMC article. Review.
339 results